BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 17936673)

  • 1. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia.
    Yan SK; Wei BJ; Lin ZY; Yang Y; Zhou ZT; Zhang WD
    Oral Oncol; 2008 May; 44(5):477-83. PubMed ID: 17936673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma.
    Zhou J; Xu B; Huang J; Jia X; Xue J; Shi X; Xiao L; Li W
    Clin Chim Acta; 2009 Mar; 401(1-2):8-13. PubMed ID: 19056370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of premalignant lesions and early cancers of the oral cavity.
    Gillenwater AM; Chambers MS
    Tex Dent J; 2006 Jun; 123(6):512-20. PubMed ID: 16875018
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma.
    Agha-Hosseini F; Mirzaii-Dizgah I; Farmanbar N; Abdollahi M
    J Oral Pathol Med; 2012 Nov; 41(10):736-40. PubMed ID: 22582895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
    Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
    Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study.
    Safadi RA; Al Jaber SZ; Hammad HM; Hamasha AA
    Arch Oral Biol; 2010 Jun; 55(6):454-61. PubMed ID: 20427035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
    Sun L; Feng J; Ma L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.
    Kaur J; Politis C; Jacobs R
    Clin Oral Investig; 2016 Mar; 20(2):315-9. PubMed ID: 26077895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral cancer: the importance of early referral.
    Hyde N; Hopper C
    Practitioner; 1999 Oct; 243(1603):753, 756-8, 760-1 passim. PubMed ID: 10715874
    [No Abstract]   [Full Text] [Related]  

  • 12. Epstein-Barr virus prevalence in oral squamous cell cancer and in potentially malignant oral disorders in an eastern Hungarian population.
    Kis A; Fehér E; Gáll T; Tar I; Boda R; Tóth ED; Méhes G; Gergely L; Szarka K
    Eur J Oral Sci; 2009 Oct; 117(5):536-40. PubMed ID: 19758249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics.
    Ishikawa S; Sugimoto M; Edamatsu K; Sugano A; Kitabatake K; Iino M
    Oral Dis; 2020 Jan; 26(1):35-42. PubMed ID: 31602722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new and preliminary three-dimensional perspective: proteomes of optimization between OSCC and OLK.
    He H; Sun G; Ping F; Cong Y
    Artif Cells Blood Substit Immobil Biotechnol; 2011 Feb; 39(1):26-30. PubMed ID: 20932085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary metabolite signatures of oral cancer and leukoplakia.
    Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
    Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK.
    He H; Sun G; Ping F
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(5):208-13. PubMed ID: 19735007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optical coherence tomography in the evaluation of the oral cavity mucosa. Part II. Benign and malignant diseases].
    Fomina IuV; Gladkova ND; Leont'ev VK; Urutina MN; Gazhva SI; Snopova LB; Gelikonov VM; Kamenskiĭ VA
    Stomatologiia (Mosk); 2004; 83(4):25-32. PubMed ID: 15340301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quiz questions. Idiopathic leukoplakia, tobacoco-induced leukoplakia, frictional keratosis, plaque lichen planus, candidal leukoplakia (chronic hyperplastic leukoplakia), squamous cell carcinoma, lichenoid reaction to drug or amalgam, or oral hairy leukoplakia.
    Healy C
    J Ir Dent Assoc; 2011; 57(4):180, 216. PubMed ID: 21922989
    [No Abstract]   [Full Text] [Related]  

  • 19. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
    Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary β2-microglobulin levels in patients with erosive oral lichen planus and squamous cell carcinoma.
    Nosratzehi F; Nosratzehi T; Alijani E; Rad SS
    BMC Res Notes; 2020 Jun; 13(1):294. PubMed ID: 32552881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.